Skip to main
UHS
UHS logo

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 23%
Buy 15%
Hold 54%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services Inc. has demonstrated significant financial performance, with its Acute Care Hospital Services segment achieving a year-over-year adjusted EBITDA margin expansion of 190 basis points to 15.8%. The Behavioral Health Services segment reported a revenue growth of 9.3%, complemented by an 8.5% increase when excluding certain volumes, indicating a positive trend in patient engagement. Additionally, the company anticipates potential additional benefits of $75-80 million from pending CMS program approvals, combined with strong pricing and revenue growth projections that suggest future profitability may outpace costs.

Bears say

The analysis highlights several factors contributing to a negative outlook on Universal Health Services's stock, particularly concerning revenue projections and operational headwinds. Key metrics indicate that fiscal year 2026 earnings may be approximately 5% below estimates due to volume and margin pressures, compounded by a downward adjustment in long-term growth expectations for behavioral health services. Furthermore, the anticipated decline in EBITDA contributions from the DPP segment and potential risks related to regulatory changes and labor market constraints add further strain on the company’s financial stability and operational efficiency.

UHS has been analyzed by 13 analysts, with a consensus rating of Hold. 23% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 13 analysts, UHS has a Hold consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $231.46, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $231.46, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.